Shelli French v. Neutrogena Corporation
Filing
27
TRANSFER ORDER re: pldg. ( #1 in MDL No. 3015) Transferring 7 action(s) to Judge Raag Singhal in the S.D. Florida.Signed by Judge Karen K. Caldwell, Chair, PANEL ON MULTIDISTRI CT LITIGATION, on 10/8/2021. Associated Cases: MDL No. 3015, CAC/2:21-cv-05048, CAN/3:21-cv-05419, CAN/3:21-cv-05524, FLS/0:21-cv-61103, NJ/3:21-cv-13113, NJ/3:21-cv-13710, NJ/3:21-cv-13972, NYS/7:21-cv-06091 (CMD)
UNITED STATES JUDICIAL PANEL
on
MULTIDISTRICT LITIGATION
IN RE: JOHNSON & JOHNSON AEROSOL SUNSCREEN
MARKETING, SALES PRACTICES AND
PRODUCTS LIABILITY LITIGATION
MDL No. 3015
TRANSFER ORDER
Before the Panel *: Plaintiffs in the District of New Jersey Jimenez action move under 28
U.S.C. § 1407 to centralize this litigation involving the alleged contamination of Neutrogena and
Aveeno-branded sunscreens made by Johnson & Johnson Consumer Inc. with benzene in the
District of New Jersey. Plaintiffs’ motion includes eight actions pending in five districts, as listed
on Schedule A, as well as nine potentially-related actions. 1 Plaintiffs in all actions support
centralization and propose one or more of the following districts: the District of New Jersey, the
Northern District of California, the Southern District of Florida, the Northern District of Alabama
and the Central District of California. Defendants Johnson & Johnson Consumer Inc. and Johnson
& Johnson (collectively, J&J) and Costco Wholesale Corporation support centralization in the
District of New Jersey or the Southern District of Florida.
After considering the argument of counsel, 2 we find that centralization of these actions in
the Southern District of Florida will serve the convenience of the parties and witnesses and
promote the just and efficient conduct of the litigation. All actions can be expected to share factual
questions arising from allegations that plaintiffs purchased sunscreens manufactured by J&J
defendants that contained excessive amounts of benzene. Plaintiffs’ claims arise from tests an
analytical pharmacy, Valisure LLC and ValisureRX LLC (Valisure), ran on a variety of sunscreen
products. Valisure reportedly tested numerous lots of spray and lotion sunscreen products from
various manufacturers and discovered that certain of the J&J defendants’ sunscreens contained
excessive levels of benzene, a known human carcinogen that has been linked to leukemia and other
*
Certain Panel members who may be members of the putative classes in this litigation have
renounced their membership in these classes and participated in this decision.
1
These actions, and any other related actions, are potential tag-along actions. See Panel Rules
1.1(h), 7.1 and 7.2.
2
In light of the concerns about the spread of COVID-19 virus (coronavirus), the Panel heard oral
argument by videoconference at its hearing session of September 30, 2021. See Suppl. Notice of
Hearing Session, MDL No. 3015 (J.P.M.L. September 13, 2021), ECF No. 72.
-2cancers. On July 14, 2021, J&J issued a voluntary recall of five affected product lines 3 from all
distribution channels, and instructed consumers to stop using them. Centralization offers
substantial opportunity to streamline pretrial proceedings; reduce duplicative discovery and
conflicting pretrial obligations; prevent inconsistent pretrial rulings (particularly on such issues as
common Daubert challenges and class certification motions); and conserve the resources of the
parties, their counsel and the judiciary.
At oral argument, the parties took varying positions on whether the MDL should include
personal injury actions alongside the consumer class actions. While all actions on the motion
before us are consumer class actions, one of the nine potential tag-along actions, Northern District
of Alabama De Los Santos, contains personal injury claims arising from plaintiff’s alleged
exposure to benzene in J&J sunscreen. Based on the parties’ arguments, there appears to be some
merit to the view that this litigation can proceed more efficiently by allowing these consumer class
cases to progress separately from the lone personal injury action. But transfer of the De Los Santos
case need not – indeed, cannot – be decided now because that case is not squarely before us.
Instead, we will address transfer of personal injury actions like De Los Santos in due course, as we
do with all potential tag-along actions. See Panel Rules 1.1(h), 7.1 and 7.2.
We are persuaded that the Southern District of Florida is the appropriate transferee district
for these cases. The first-filed case is pending in this district before Judge Anuraag Singhal. The
Southern District of Florida offers a convenient and readily accessible district. By selecting Judge
Singhal, we are selecting a jurist who has not yet had the opportunity to preside over multidistrict
litigation. We are confident that Judge Singhal will steer this litigation on a prudent course.
IT IS THEREFORE ORDERED that the actions listed on Schedule A and pending outside
the Southern District of Florida are transferred to the Southern District of Florida and, with the
consent of that court, assigned to the Honorable Anuraag Singhal for coordinated or consolidated
proceedings with the action pending there and listed on Schedule A.
IT IS FURTHER ORDERED that, because this litigation involves both aerosol and lotion
sunscreens, the litigation caption is hereby changed to “IN RE: Johnson & Johnson Sunscreen
Marketing, Sales Practices and Products Liability Litigation.”
3
The recall included: Neutrogena Beach Defense aerosol sunscreen, Neutrogena Cool Dry Sport
aerosol sunscreen, Neutrogena Invisible Daily defense aerosol sunscreen, Neutrogena Ultra Sheer
aerosol sunscreen and Aveeno Protect + Refresh aerosol sunscreen. Several plaintiffs contend that
this recall was inadequate and should have included other J&J sunscreen products.
-3PANEL ON MULTIDISTRICT LITIGATION
_______________________________________
Karen K. Caldwell
Chair
Catherine D. Perry
Matthew F. Kennelly
Roger T. Benitez
Nathaniel M. Gorton
David C. Norton
Dale A. Kimball
IN RE: JOHNSON & JOHNSON AEROSOL SUNSCREEN
MARKETING, SALES PRACTICES AND
PRODUCTS LIABILITY LITIGATION
MDL No. 3015
SCHEDULE A
Central District of California
SHELLI FRENCH v. NEUTROGENA CORPORATION, C.A. No. 2:21−05048
Northern District of California
DOMINGUEZ, ET AL. v. JOHNSON & JOHNSON CONSUMER, INC., C.A. No. 3:21−05419
RAFAL v. JOHNSON & JOHNSON, ET AL., C.A. No. 3:21−05524
Southern District of Florida
SEROTA v. NEUTROGENA CORPORATION, ET AL., C.A. No. 0:21−61103
District of New Jersey
JIMENEZ, ET AL. v. JOHNSON & JOHNSON CONSUMER, INC., C.A. No. 3:21−13113
MCLAUGHLIN v. JOHNSON & JOHNSON CONSUMER, INC., ET AL., C.A. No. 3:21−13710
BRIGLIO v. JOHNSON & JOHNSON CONSUMER, INC., C.A. No. 3:21−13972
Southern District of New York
LAVALLE v. NEUTROGENA CORPORATION, ET AL., C.A. No. 7:21−06091
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?